Plan with Express Scripts

I still hold a good amount of Express Scripts (Ticker: ESRX) shares acquired from the Medco merger with a cost basis of $56.49 (based on the fair value of Express Scripts at closing of the merger). I did sell some back in April at $58.44 to add to the Motorola Mobility merger arb play. My original plan was to sell the rest of my holding in Express Scripts when it reached ~ $60, but after yesterdays earnings release I’ve changed my plans. Express Scripts has a lot more room to run and will hang on as long as they show good numbers.